Back to Company Profile
Alpha

Alpha Profiles · Company Profile

IN8BIO, INC.

IN8bio, Inc. is a biotechnology firm currently in the clinical trial phase, dedicated to identifying, advancing, and bringing to market gamma-delta T cell-based treatments specifically for various forms of cancer.

https://registry.alpha.ac/companies/in8bio-inc

IN8BIO, INC. logo
Entity
Public listing published
Primary listing
NASDAQ: INAB
Verification
Partially verified
Last reviewed
2026-10-13T04:47:15.571386+00:00

Overview

IN8bio, Inc. is a biotechnology firm currently in the clinical trial phase, dedicated to identifying, advancing, and bringing to market gamma-delta T cell-based treatments specifically for various forms of cancer. The company's primary therapeutic asset, INB-200, is an autologous (patient-derived) gamma-delta T cell product that has been genetically engineered and is presently undergoing a Phase I clinical study for glioblastoma and other solid tumor malignancies.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

0 public records

Executive roster coverage is NOT_ASSERTED. An empty list is not evidence that this company has no executive team.

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

6 public records

Committees

3 public records

Membership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.

Audit

Chair
Peter Brandt
Members
Peter Brandt (Chair); Corinne Epperly; Luba Greenwood

Compensation

Chair
Luba Greenwood
Members
Luba Greenwood (Chair); Corinne Epperly; Peter Brandt

Nominating and Governance

Chair
Jeremy Graff
Members
Jeremy Graff (Chair); Emily Fairbairn; Peter Brandt

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-10-13T04:47:15.571386+00:00

Generated 2026-10-13T17:11:23.461Z

Data as of 2026-10-13T04:47:15.571386+00:00

https://registry.alpha.ac/companies/in8bio-inc